SMC - June 2021 decisions

7 June 2021 - Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia ...

Read more →

Pilot of new health technology evaluation process for antimicrobials

7 May 2021 - Research to develop novel antibiotics has in recent years been seen as commercially unattractive due to limited ...

Read more →

Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use

10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...

Read more →

SMC - May 2021 decisions

10 May 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has announced today that ...

Read more →

Scotland opens door to Translarna for Duchenne muscular dystrophy

13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...

Read more →

Four medicines accepted for use by NHS Scotland

13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...

Read more →

SMC - April 2021 decisions

12 April 2021 - Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today ...

Read more →

Development of an international template to support patient submissions in health technology assessments

1 April 2021 - The objective was to develop an international template to support patient submissions in health technology assessments.  ...

Read more →

World's most expensive drug given the green light in Scotland

8 March 2021 - A medicine known as the most expensive in the world has been approved to treat a rare ...

Read more →

SMC - March 2021 decisions

8 March 2021 - Medicines which can be used to treat a rare genetic disease in children and some cancer ...

Read more →

Scottish Medicines Consortium accepts Prostap SR DCS & Prostap 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer

8 February 2021 - Takeda is pleased to announce that the Scottish Medicines Consortium has accepted Prostap SR DCS & ...

Read more →

Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide

8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...

Read more →

SMC issues positive decision for treatment with AbbVie’s Rinvoq (upadacitinib) in severe active rheumatoid arthritis

9 February 2021 - Positive indication means upadacitinib will be available to those with previously treated severe active rheumatoid arthritis. ...

Read more →

Scotland approves MS drug that was rejected in England and Wales

9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...

Read more →

SMC - February 2021 decisions

8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →